Ruyuan Yu

755 total citations · 1 hit paper
20 papers, 514 citations indexed

About

Ruyuan Yu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruyuan Yu has authored 20 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruyuan Yu's work include RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Ruyuan Yu is often cited by papers focused on RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Ruyuan Yu collaborates with scholars based in China, United States and France. Ruyuan Yu's co-authors include Jun Li, Shuxia Zhang, Miaoling Tang, Libing Song, Yameng Hu, Ziwen Li, Xinyi Liao, Meisongzhu Yang, Xingui Wu and Xincheng Li and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Molecular Cell.

In The Last Decade

Ruyuan Yu

19 papers receiving 508 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

LPCAT1-mediated membrane phospholipid remodelling promotes ferroptosis evasion and tumour growth

2024 60 citations Yameng Hu, Haiqing Zheng et al. Nature Cell Biology profile →

Peers

Ruyuan Yu

PRM

ONCOL

IMMUN

Dong-Min Shi China

Shaowen Jiang United States

Jun Wen China

Yunhua Xu China

Mehrdokht Sadrkhanloo Iran

Ramesh Elango Qatar

Jie Ju China

Peiyan Hua China

Hai-Yu Mo China

Xiaoyun Song China

Dong-Min Shi China

Ruyuan Yu

332 ×0.8

245 ×1.1

55 ×0.6

PRM

80 ×1.1

ONCOL

43 ×1.0

IMMUN

Citations per year, relative to Ruyuan Yu Ruyuan Yu (= 1×) peers Dong-Min Shi

Countries citing papers authored by Ruyuan Yu

Since Specialization

Citations

This map shows the geographic impact of Ruyuan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruyuan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruyuan Yu more than expected).

Fields of papers citing papers by Ruyuan Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruyuan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruyuan Yu. The network helps show where Ruyuan Yu may publish in the future.

Co-authorship network of co-authors of Ruyuan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Ruyuan Yu. A scholar is included among the top collaborators of Ruyuan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruyuan Yu. Ruyuan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Yameng, Xingui Wu, Shuxia Zhang, et al.. (2025). Targeting PRDX6-dependent localization and function of GPX4 enhances ferroptosis-mediated tumor suppression. Molecular Cell. 85(24). 4602–4620.e9.

Tang, Miaoling, Shuxia Zhang, Meisongzhu Yang, et al.. (2024). Infiltrative Vessel Co-optive Growth Pattern Induced by IQGAP3 Overexpression Promotes Microvascular Invasion in Hepatocellular Carcinoma. Clinical Cancer Research. 30(10). 2206–2224. 7 indexed citations

Hu, Yameng, Haiqing Zheng, Xincheng Li, et al.. (2024). LPCAT1-mediated membrane phospholipid remodelling promotes ferroptosis evasion and tumour growth. Nature Cell Biology. 26(5). 811–824. 60 indexed citations breakdown →

Zhang, Shuxia, Xincheng Li, Xingui Wu, et al.. (2024). Dynamic structural remodeling of LINC01956 enhances temozolomide resistance in MGMT -methylated glioblastoma. Science Translational Medicine. 16(767). eado1573–eado1573. 5 indexed citations

Li, Ziwen, Xinyi Liao, Yameng Hu, et al.. (2023). SLC27A4-mediated selective uptake of mono-unsaturated fatty acids promotes ferroptosis defense in hepatocellular carcinoma. Free Radical Biology and Medicine. 201. 41–54. 26 indexed citations

Liao, Xinyi, Haiqing Zheng, Shuxia Zhang, et al.. (2023). Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the FBXO32/NF-κB/MGMT Axis. Molecular Cancer Research. 21(7). 648–663. 6 indexed citations

Xu, Yingru, Xincheng Li, Shuxia Zhang, et al.. (2023). CircMMP2(6,7) Cooperates with β-Catenin and PRMT5 to Disrupt Bone Homeostasis and Promote Breast Cancer Bone Metastasis. Cancer Research. 84(2). 328–343. 12 indexed citations

Ren, Liangliang, Wenjie Lu, Weijian Zhang, et al.. (2023). The DDUP protein encoded by the DNA damage-induced CTBP1-DT lncRNA confers cisplatin resistance in ovarian cancer. Cell Death and Disease. 14(8). 568–568. 25 indexed citations

Zhang, Shuxia, Xinyi Liao, Suwen Chen, et al.. (2022). Large Oncosome‐Loaded VAPA Promotes Bone‐Tropic Metastasis of Hepatocellular Carcinoma Via Formation of Osteoclastic Pre‐Metastatic Niche. Advanced Science. 9(31). e2201974–e2201974. 29 indexed citations

10.

Wu, Xingui, Ruyuan Yu, Meisongzhu Yang, et al.. (2022). Integrated Analysis of Glutathione Metabolic Pathway in Pancreatic Cancer. Frontiers in Cell and Developmental Biology. 10. 896136–896136. 3 indexed citations

11.

Yu, Ruyuan, Yameng Hu, Shuxia Zhang, et al.. (2022). LncRNA CTBP1-DT-encoded microprotein DDUP sustains DNA damage response signalling to trigger dual DNA repair mechanisms. Nucleic Acids Research. 50(14). 8060–8079. 32 indexed citations

12.

Tang, Miaoling, Meisongzhu Yang, Geyan Wu, et al.. (2021). Epigenetic Induction of Mitochondrial Fission Is Required for Maintenance of Liver Cancer–Initiating Cells. Cancer Research. 81(14). 3835–3848. 52 indexed citations

13.

Xu, Yingru, Shuxia Zhang, Xinyi Liao, et al.. (2021). Circular RNA circIKBKB promotes breast cancer bone metastasis through sustaining NF-κB/bone remodeling factors signaling. Molecular Cancer. 20(1). 98–98. 78 indexed citations

14.

Zhang, Shuxia, Yingru Xu, Chan Xie, et al.. (2020). RNF219/α‐Catenin/LGALS3 Axis Promotes Hepatocellular Carcinoma Bone Metastasis and Associated Skeletal Complications. Advanced Science. 8(4). 2001961–2001961. 30 indexed citations

15.

Cao, Lixue, Geyan Wu, Jinrong Zhu, et al.. (2019). Genotoxic stress-triggered β-catenin/JDP2/PRMT5 complex facilitates reestablishing glutathione homeostasis. Nature Communications. 10(1). 3761–3761. 41 indexed citations

16.

Wu, Geyan, Lixue Cao, Jinrong Zhu, et al.. (2018). Loss of RBMS3 Confers Platinum Resistance in Epithelial Ovarian Cancer via Activation of miR-126-5p/β-catenin/CBP signaling. Clinical Cancer Research. 25(3). 1022–1035. 45 indexed citations

17.

Liu, Qianqian, et al.. (2018). Research on mode division multiplexer with graded-index distribution, low loss and low crosstalk. Optoelectronics Letters. 14(5). 336–341. 3 indexed citations

18.

Wang, Yang, Ruyuan Yu, Jing Zhang, et al.. (2017). Inhibition of Nrf2 enhances the anticancer effect of 6-O-angeloylenolin in lung adenocarcinoma. Biochemical Pharmacology. 129. 43–53. 35 indexed citations

19.

Wang, Yang, Zhi‐Hao Huang, Ruyuan Yu, et al.. (2016). Dynamic quantitative proteomics characterization of TNF-α-induced necroptosis. APOPTOSIS. 21(12). 1438–1446. 10 indexed citations

20.

Wang, Yang, Ruyuan Yu, & Qing‐Yu He. (2015). Proteomic Analysis of Anticancer TCMs Targeted at Mitochondria. Evidence-based Complementary and Alternative Medicine. 2015. 1–14. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact